After decades of operating Hong Kong’s marquee airline and coke bottling factories in China, Swire Pacific Ltd. is diversifying into a new line of business: private hospitals in China and Southeast Asia.
It has agreed in principal to acquire a controlling stake in DeltaHealth China Ltd., a hospital in Shanghai specializing in heart and vascular care. The purchase will mark the first health-care project where Swire leads the operation, as the Hong Kong-based conglomerate seeks to boost growth.
